ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,200Medicare Part D Prescriptions Filled, Including Refills

Rank: 386 out of 4623

$254K Total Retail Price of All Prescriptions

Rank: 1925 out of 4623

542 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
51% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

16% of this provider’s 542 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

6% of this provider’s 9,142 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

13% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$23 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
SIMVASTATIN 1,044 917 1 2
FUROSEMIDE 801 671 2 8
ALENDRONATE SODIUM 402 342 3 22
VERAPAMIL ER 388 337 4 96
VITAMIN D2 374 327 5 304
LISINOPRIL 361 283 6 4
ALLOPURINOL 317 246 7 37
TRIAMTERENE-HCTZ 293 253 8 80
LISINOPRIL-HYDROCHLOROTHIAZIDE 273 233 9 19
AMLODIPINE BESYLATE 261 217 10 5
LEVOTHYROXINE SODIUM 252 180 11 1
METFORMIN HCL 251 215 12 6
ATENOLOL 231 172 13 28
ENALAPRIL MALEATE 226 166 14 41
TERBINAFINE HCL 217 167 10 15 323
POTASSIUM CHLORIDE 197 147 16 14
TRAMADOL HCL 175 123 17 15
NIFEDIPINE ER 169 155 18 97
AMLODIPINE BESYLATE-BENAZEPRIL 143 131 19 55
HYDROCODONE-ACETAMINOPHEN 136 125 S3 20 3
CAPTOPRIL 133 132 21 215
TRIAMTERENE-HYDROCHLOROTHIAZID 132 105 22 234
OMEPRAZOLE 130 119 23 7
NAPROXEN 125 98 24 63
METOPROLOL TARTRATE 120 109 25 9
GLYBURIDE MICRONIZED 111 105 R 26 205
GLYBURIDE 110 97 R 27 59
AMOXICILLIN 105 66 28 95
ACETAMINOPHEN-CODEINE 99 58 S3 29 144
AMILORIDE-HYDROCHLOROTHIAZIDE 98 85 30 288
HYDROCHLOROTHIAZIDE 95 64 31 10
METOPROLOL SUCCINATE 87 60 32 13
GLYBURIDE-METFORMIN HCL 81 77 R 33 56
LEVOCETIRIZINE DIHYDROCHLORIDE 79 60 34 221
CLEMASTINE FUMARATE 77 56 R 35 344
LOSARTAN POTASSIUM 74 65 36 21
HUMALOG MIX 75-25 73 70 37 307
MELOXICAM 72 61 38 27
ZOLPIDEM TARTRATE 66 39 39 18
DIOVAN 64 64 40 39
PREDNISONE 60 34 41 50
IBUPROFEN 60 44 41 65
CARVEDILOL 58 55 43 25
AMMONIUM LACTATE 57 50 44 328
DIGOXIN 54 54 45 58
DICLOFENAC SODIUM 51 42 46 121
INDOMETHACIN 50 47 R 47 312
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 3, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.